Fisher Asset Management’s Zymeworks ZYME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.54M Buy
101,439
+33,242
+49% +$787K ﹤0.01% 540
2025
Q4
$1.8M Sell
68,197
-3,777
-5% -$82.4K ﹤0.01% 574
2025
Q3
$1.23M Sell
71,974
-5
-0% -$72 ﹤0.01% 658
2025
Q2
$903K Buy
71,979
+5
+0% +$60 ﹤0.01% 707
2025
Q1
$857K Buy
71,974
+8,374
+13% +$114K ﹤0.01% 710
2024
Q4
$931K Hold
63,600
﹤0.01% 667
2024
Q3
$798K Hold
63,600
﹤0.01% 689
2024
Q2
$541K Buy
+63,600
New +$566K ﹤0.01% 772

Other funds holding ZYME

Fisher Asset Management's ZYME Position: Q1 2026 in Review

Fisher Asset Management increased its Zymeworks (ZYME) stake by 49% in Q1 2026, buying an estimated $787K and bringing the position to 101,439 shares worth $2.54M. The position accounts for ﹤0.01% of the portfolio, ranked #540.

Fisher Asset Management first reported a position in ZYME in Q2 2024 and has held it in 8 quarters since. 211 funds tracked by Wall St. Rank hold ZYME as of Q1 2026.

  • Fisher Asset Management held 101,439 shares of Zymeworks worth $2.54M as of Q1 2026.
  • Fisher Asset Management bought 33,242 Zymeworks shares in Q1 2026, an estimated $787K.
  • Zymeworks made up ﹤0.01% of Fisher Asset Management's portfolio in Q1 2026, its #540 holding.
  • Fisher Asset Management first reported a position in Zymeworks in Q2 2024 and has held it in 8 quarters since.
  • 211 funds tracked by Wall St. Rank held Zymeworks as of Q1 2026.

Based on Fisher Asset Management's 13F filing for Q1 2026, filed 5 May 2026.